尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Manke Isaac. Officer active across 2 companies, notably OnKure Therapeutics, Inc.. Aggregated, 6 disclosures have been published. Activity tracked since 31 March 2025. The latest transaction was filed on 2 September 2026 (Disposition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Manke Isaac is a declarant linked to OnKure Therapeutics, Inc. and Addex Therapeutics Ltd., where he is a director. The record contains 6 filings, with sampled filings from 2025-04-02 to 2026-09-04, and the modal transaction nature is Attribution.